CB2 Insights is Driving the Cannabis Industry Through Business Intelligence: CEO

Published:

CB2 Insights Inc operates one of the largest networks of medical centres for cannabis evaluation in the United States


In this interview at the recent Cantech Investment Conference 2019 in Toronto, SmallCapPower spoke with Prad Sekar, CEO of CB2 Insights Inc, about the Company’s mission to use data sets and business intelligence to educate the medical community about the use of cannabis, as well as its efficacy and role within a patient’s treatment plan. Watch our short video to find out how CB2 Insights plans to adopt an aggressive acquisition strategy in 2019 as well as list on the Canadian Securities Exchange.

To read our full disclosure, please click on the button below:

Related articles

Recent articles